Literature DB >> 27558198

Clinical course and short-term mortality of cirrhotic patients with infections other than spontaneous bacterial peritonitis.

Javier Fernández1,2,3,4, Juan Acevedo1,2,3, Verónica Prado1,2,3, Mario Mercado1, Miriam Castro1,2,3, Marco Pavesi4, Mireya Arteaga1,2,3, Lydia Sastre1,2,3, Adria Juanola1, Pere Ginès1,2,3,4, Vicente Arroyo1,2,3,4.   

Abstract

BACKGROUND & AIMS: Clinical course and risk factors of death in non-spontaneous bacterial peritonitis (SBP) infections are poorly known. We assessed the prevalence of acute kidney injury (AKI) and type-1 hepatorenal syndrome (HRS), hospital, 30-day and 90-day mortality and risk factors of death in 441 decompensated patients.
METHODS: Analysis of 615 non-SBP infections (161 urinary infections (UTI), 95 cellulitis, 92 suspected infections, 92 bacteraemias, 84 pneumonias, 21 bronchitis, 18 cholangitis, 15 spontaneous empyema, 13 secondary peritonitis, 24 other).
RESULTS: Ninety-six percent of infections solved. AKI and type-1 HRS were developed in 37% and 9% of infections respectively. Overall hospital, 30-day and 90-day mortality rates were 11%, 12% and 18% respectively. Clinical course and mortality differed markedly across infections. Endocarditis, osteoarticular infections, pneumonia, spontaneous bacteraemia, cholangitis, secondary peritonitis and UTI showed higher rates of AKI. Prevalence of type-1 HRS was not significantly different among infections. Endocarditis, secondary peritonitis, pneumonia and bacteraemia showed lower rates of renal impairment resolution and higher hospital mortality associated with AKI (42% vs 12%, P<.0001) or type-1 HRS (71% vs 27%, P=.003) than the rest of infections. Age (HR: 1.04), serum sodium (HR: 0.91), serum bilirubin (HR: 1.06), INR (HR: 1.91), hepatic encephalopathy (HR: 2.44), ascites (HR: 3.06) and multidrug-resistant isolation (HR: 2.27) at infection diagnosis were independent predictors of death during hospitalization.
CONCLUSIONS: Non-SBP infections constitute a heterogeneous group regarding clinical course and prognosis. Endocarditis, secondary peritonitis, pneumonia and bacteraemia show worse prognosis. The combination of data of liver and renal dysfunction and of the type of infection allows the identification of patients with poor prognosis.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  acute kidney injury; bacteraemia; circulatory dysfunction; pneumonia; renal impairment; type-1 HRS

Mesh:

Year:  2016        PMID: 27558198     DOI: 10.1111/liv.13239

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  9 in total

1.  Role of the cytochrome P-450/ epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis.

Authors:  Michael M Yeboah; Md Abdul Hye Khan; Marla A Chesnik; Melissa Skibba; Lauren L Kolb; John D Imig
Journal:  Nephrol Dial Transplant       Date:  2018-08-01       Impact factor: 5.992

2.  Spontaneous bacteremia and spontaneous bacterial peritonitis in cirrhosis: two infections but similar outcomes?

Authors:  Rakhi Maiwall
Journal:  Hepatol Int       Date:  2018-03-27       Impact factor: 6.047

Review 3.  Acute kidney injury: prediction, prognostication and optimisation for liver transplant.

Authors:  Nishita Jagarlamudi; Florence Wong
Journal:  Hepatol Int       Date:  2020-03-03       Impact factor: 6.047

4.  Analysis of Risk Factors for Patients with Liver Cirrhosis Complicated with Spontaneous Bacterial Peritonitis.

Authors:  Yuan Wang; Qingyu Zhang
Journal:  Iran J Public Health       Date:  2018-12       Impact factor: 1.429

5.  Spontaneous bacteremia and spontaneous bacterial peritonitis share similar prognosis in patients with cirrhosis: a cohort study.

Authors:  Sebastián Marciano; Melisa Dirchwolf; Carla S Bermudez; Natalia Sobenko; Leila Haddad; Federico Genre Bert; Laura Barcán; Astrid Smud; Maria Lourdes Posadas-Martínez; Diego Giunta; Adrián Gadano
Journal:  Hepatol Int       Date:  2017-12-09       Impact factor: 6.047

6.  The role of prophylactic antibiotics in hepatitis B virus-related acute-on-chronic liver failure patients at risk of bacterial infection: a retrospective study.

Authors:  Xiao-Qin Liu; Xue-Yun Zhang; Yue Ying; Jian-Ming Zheng; Jian Sun; Wen-Hong Zhang; Ji-Ming Zhang; Yu-Xian Huang
Journal:  Infect Dis Poverty       Date:  2021-03-31       Impact factor: 4.520

Review 7.  Albumin administration in patients with cirrhosis: Current role and novel perspectives.

Authors:  Ângelo Zambam de Mattos; Douglas Alano Simonetto; Carlos Terra; Alberto Queiroz Farias; Paulo Lisboa Bittencourt; Tales Henrique Soares Pase; Marlon Rubini Toazza; Angelo Alves de Mattos
Journal:  World J Gastroenterol       Date:  2022-09-07       Impact factor: 5.374

8.  Infection deteriorating hepatitis B virus related acute-on-chronic liver failure: a retrospective cohort study.

Authors:  Xing-Ran Zhai; Jing-Jing Tong; Hong-Min Wang; Xiang Xu; Xiu-Ying Mu; Jing Chen; Zi-Feng Liu; Yu Wang; Hai-Bin Su; Jin-Hua Hu
Journal:  BMC Gastroenterol       Date:  2020-09-29       Impact factor: 3.067

9.  Rifaximin has the potential to prevent complications of cirrhosis.

Authors:  Steven L Flamm; Kevin D Mullen; Zeev Heimanson; Arun J Sanyal
Journal:  Therap Adv Gastroenterol       Date:  2018-09-28       Impact factor: 4.409

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.